U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 44

1.
Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis
Yi Zhang, Zheng Li, Ying Huang, Bingwen Zou, Yong Xu
BMJ Open. 2024; 14(1): e073887. Published online 2024 Jan 31. doi: 10.1136/bmjopen-2023-073887
PMCID:
PMC10831450
AbstractArticlePDF–2.1M
2.
Cyclin‐dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial‐mesenchymal transition‐like process in glioma by activating TGFβ/SMAD signaling
Fan Feng, Zongqing Zhao, Xuechang Cai, Xueyuan Heng, Ximeng Ma
Cancer Med. 2023 Mar; 12(5): 5889–5907. Published online 2022 Oct 25. doi: 10.1002/cam4.5381
PMCID:
PMC10028050
AbstractArticlePDF–38M
3.
Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I–III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity
Junkai Feng, Menglong Hu, Zongkuo Li, Guiming Hu, Yuting Han, Yan Zhang, Min Zhang, Jingli Ren
Cells. 2022 Aug; 11(16): 2611. Published online 2022 Aug 22. doi: 10.3390/cells11162611
PMCID:
PMC9406629
AbstractArticlePDF–10M
4.
High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
Kai Yu, Yulong Ji, Min Liu, Fugeng Shen, Xiaoxing Xiong, Lijuan Gu, Tianzhu Lu, Yingze Ye, Shi Feng, Jianying He
Front Immunol. 2022; 13: 881453. Published online 2022 May 19. doi: 10.3389/fimmu.2022.881453
PMCID:
PMC9160311
AbstractArticlePDF–13M
5.
CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry
Menglong Hu, Zongkuo Li, Jinhuan Qiu, Ruizhen Zhang, Junkai Feng, Guiming Hu, Jingli Ren
Bioengineered. 2021; 12(1): 5996–6009. Published online 2021 Sep 8. doi: 10.1080/21655979.2021.1972197
PMCID:
PMC8806895
AbstractArticlePDF–3.0M
6.
Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma
Jie Zhang, Qianqian Song, Jinxia Liu, Lina Lu, Yuqing Xu, Wenjie Zheng
Dis Markers. 2019; 2019: 8964015. Published online 2019 Oct 22. doi: 10.1155/2019/8964015
PMCID:
PMC6855053
AbstractArticlePDF–3.0M
7.
Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer
Naiqi Huang, Zuli Wu, Hong Hong, Xiangming Wang, Fengqiang Yang, Hengguo Li
Mol Med Rep. 2019 Jun; 19(6): 4761–4769. Published online 2019 Apr 5. doi: 10.3892/mmr.2019.10134
PMCID:
PMC6522797
AbstractArticlePDF–1.4M
8.
Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer
Marte Jonsson, Christina Sæten Fjeldbo, Ruth Holm, Trond Stokke, Gunnar Balle Kristensen, Heidi Lyng
Neoplasia. 2019 Apr; 21(4): 353–362. Published online 2019 Mar 8. doi: 10.1016/j.neo.2019.01.002
PMCID:
PMC6411633
AbstractArticlePDF–2.3M
9.
Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance
Jiani Wang, Lihua Xu, Yu Liu, Jianning Chen, Hua Jiang, Shaojiang Yang, Huo Tan
Int J Clin Exp Pathol. 2014; 7(12): 8593–8601. Published online 2014 Dec 1.
PMCID:
PMC4313994
AbstractArticlePDF–1.0M
10.
Cks Overexpression Enhances Chemotherapeutic Efficacy by Overriding DNA Damage Checkpoints
Sonia V. del Rincón, Martin Widschwendter, Dahui Sun, Susanna Ekholm-Reed, John Tat, Leonardo K. Teixeira, Zdenka Ellederova, Elise Grolieres, Steven I. Reed, Charles Spruck
Oncogene. Author manuscript; available in PMC 2015 Oct 9.
Published in final edited form as: Oncogene. 2015 Apr 9; 34(15): 1961–1967. Published online 2014 May 26. doi: 10.1038/onc.2014.137
PMCID:
PMC4245389
AbstractArticlePDF–407K
11.
Errate: Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis
Zhengqing Yang, Hui Cheng, Yazhou Zhang, Yan Zhou
Med Sci Monit. 2022; 28: e937786-1–e937786-3. Prepublished online 2022 Jul 18. Published online 2022 Jul 28. doi: 10.12659/MSM.937786
Corrects:
Med Sci Monit. 2021; 27: e928523-1–e928523-14.
PMCID:
PMC9344881
CorrectionPDF–1.1M
12.
Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis
Zhengqing Yang, Hui Cheng, Yazhou Zhang, Yan Zhou
Med Sci Monit. 2021; 27: e928523-1–e928523-14. Prepublished online 2020 Dec 31. Published online 2021 Mar 5. doi: 10.12659/MSM.928523
Correction in:
Med Sci Monit. 2022; 28: e937786-1–e937786-3.
PMCID:
PMC7941762
AbstractArticlePDF–4.1M
13.
Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells
LINGQING LIN, ZANXI FANG, HUAYUE LIN, HANYU YOU, JIAJIA WANG, YUANHUI SU, FEN WANG, ZHONG-YING ZHANG
Oncol Rep. 2016 Jan; 35(1): 26–32. Published online 2015 Nov 2. doi: 10.3892/or.2015.4372
PMCID:
PMC4699626
AbstractArticlePDF–1.3M
14.
DNA Microarray Analysis Identifies CKS2 and LEPR as Potential Markers of Meningioma Recurrence
Francesca Menghi, Francesca N. Orzan, Marica Eoli, Mariangela Farinotti, Emanuela Maderna, Federica Pisati, Donatella Bianchessi, Lorella Valletta, Sandro Lodrini, Giuseppe Galli, Elena Anghileri, Serena Pellegatta, Bianca Pollo, Gaetano Finocchiaro
Oncologist. 2011 Oct; 16(10): 1440–1450. Published online 2011 Sep 23. doi: 10.1634/theoncologist.2010-0249
PMCID:
PMC3228068
AbstractArticlePDF–1.9M
15.
The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability
William Grey, Adam Ivey, Thomas A. Milne, Torsten Haferlach, David Grimwade, Frank Uhlmann, Edwige Voisset, Veronica Yu
Biochim Biophys Acta. 2018 Jan; 1865(1): 105–116. doi: 10.1016/j.bbamcr.2017.09.009
PMCID:
PMC5701546
AbstractArticle
16.
Clinical significance and expression of cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma
Jia-Jia Wang, Zan-Xi Fang, Hui-Ming Ye, Pan You, Min-Jing Cai, Hong-Bing Duan, Fen Wang, Zhong-Ying Zhang
Dis Esophagus. Author manuscript; available in PMC 2016 Mar 18.
Published in final edited form as: Dis Esophagus. 2013 Sep-Oct; 26(7): 729–736. Published online 2013 Jan 10. doi: 10.1111/dote.12013
PMCID:
PMC4797631
AbstractArticlePDF–674K
17.
Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer
Letizia Mezzasoma, Cinzia Antognelli, Chiara Del Buono, Fabrizio Stracci, Emanuele Cottini, Giovanni Cochetti, Vincenzo N Talesa, Ettore Mearini
BMC Urol. 2010; 10: 17. Published online 2010 Oct 4. doi: 10.1186/1471-2490-10-17
PMCID:
PMC2959011
AbstractArticlePDF–669K
18.
Mutations at sites involved in Suc1 binding inactivate Cdc2.
B Ducommun, P Brambilla, G Draetta
Mol Cell Biol. 1991 Dec; 11(12): 6177–6184. doi: 10.1128/mcb.11.12.6177
PMCID:
PMC361799
SummaryPage BrowsePDF–1.6M
19.
Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins
Vasco Liberal, Hanna-Stina Martinsson-Ahlzén, Jennifer Liberal, Charles H. Spruck, Martin Widschwendter, Clare H. McGowan, Steven I. Reed
Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8): 2754–2759. Published online 2011 Jun 22. doi: 10.1073/pnas.1102434108
PMCID:
PMC3286935
AbstractArticlePDF–962K
20.
Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death
Yongsheng Lan, Yongyou Zhang, Jianghua Wang, Chunhong Lin, Michael M. Ittmann, Fen Wang
Int J Cancer. Author manuscript; available in PMC 2012 Jan 21.
Published in final edited form as: Int J Cancer. 2008 Aug 1; 123(3): 543–551. doi: 10.1002/ijc.23548
PMCID:
PMC3262990
AbstractArticlePDF–1.4M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center